The disposition of pyrantel in the gastrointestinal tract and effect of digesta flow rate on the kinetic behaviour of pyrantel in the pig.
Pigs consuming a diet with slow digesta transit time were orally administered with molar equivalent doses of pyrantel as the citrate and pamoate salt. At appropriate intervals pigs were killed and the quantitative-time distribution of pyrantel throughout the gut contents was determined. Compared with the citrate, there appeared to be greater quantities of the less soluble pamoate salt in the small and large intestine. An additional group of pigs fed on diets with "slow" or "fast" digesta transit time were orally treated with molar equivalent amounts of pyrantel as the citrate and pamoate salt and the respective kinetic disposition of pyrantel in peripheral plasma and quantitative excretion in faeces was determined. The diet type had little effect on pyrantel availability after administration of the less soluble pamoate salt. However, the maximum concentration of pyrantel in plasma was lower and there appeared to be greater quantities of pyrantel retained in the gut and excreted in faeces when the citrate salt was orally administered to pigs fed the "fast" compared to the "slow" diet. Since it is the quantity of pyrantel contained in the gut lumen which is believed to affect efficacy against gastrointestinal parasites, greater efficacy with this anthelmintic should be obtained when pigs are consuming a high fibre diet.
Hennessy
D R
DR
Danish Centre for Experimental Parasitology, Royal Veterinary and Agricultural University, Bulowsvej 13, DK-1870, Frederiksberg C, Denmark. d.hennessy@anprod.csiro.au
Praslicka
J
J
Bjørn
H
H
D000284:Administration, Oral; D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001682:Biological Availability; D004043:Dietary Fiber / Q000378:metabolism; D004064:Digestive System / Q000378:metabolism*; D005243:Feces / Q000737:chemistry; D005260:Female; D005769:Gastrointestinal Motility / Q000502:physiology*; D007408:Intestinal Absorption; D011715:Pyrantel / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013552:Swine / Q000378:metabolism*
D000969:Antinematodal Agents; D004043:Dietary Fiber; D011715:Pyrantel